6505--Amiodarone HCL Tablets 36E79726R0014
Summary
AI-generated · Mar 09, 2026Supply Amiodarone HCL tablets to VA, including CMOPs, and DoD, BOP, IHS, and FHCC under an unrestricted contract. One contractor will be awarded a single agreement that provides an uninterrupted source of supply for the listed products over a 1-year base period plus four 1-year option years, with distribution through the VA and DoD Prime Vendor Programs. Offerors must use the exact drug name on the label and have a unique NDC registered to their company; the contractor’s label will be the only label on the product, and VA labels must securely adhere over it.
Packaging and labeling requirements include unit-of-use packaging for items 1 and 2 (30-count and 60-count bottles); item 3 uses non–unit-of-use packaging. Containers must have a safety cap that can be deshelled or converted to a non-safety cap, a minimum bottle volume of 120 cc, and a cylindrical body with at least 5.75 inches of circumference. The label must fit within a 5.25 x 2 inch area, leaving an extra 0.5 inch for barcode, expiration date, and lot number. Updates and solicitation details will be posted electronically on SAM.gov; there are no paper copies or phone requests.
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0014 for an unrestricted procurement for Amiodarone Hydrochloride (HCL) Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 2 below; 30 and 60 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation #36E79726R0014 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about March 11, 2026, with a tentative closing date of March 25, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to Deborah.Fassl@va.gov. The estimated annual requirements are as follows: ITEM DESCRIPTION UNIT of USE PKG. SIZE (Tablets per Bottles) TOTAL EST. ANNUAL USAGE (Bottles) 1 AMIODARONE HCL 100 MG TABLET Y 30 54,951 2 AMIODARONE HCL 200 MG TABLET Y 60 108,834 3 AMIODARONE HCL 200 MG TABLET N 500 18,775
From Presolicitation posted on Mar 05, 2026N/A
From Solicitation posted on Mar 17, 2026N/A
From Solicitation posted on Mar 23, 2026N/A
From Solicitation posted on Apr 07, 2026Notice history
4-
-
Solicitation Posted Mar 17, 2026View changes (4)
- Description: Description was updated
- Notice Type: Presolicitation → Solicitation
- Response Deadline: Mar 19, 2026 → Mar 31, 2026
- Set-Aside: None → None
-
Solicitation LATEST Posted Apr 07, 2026View changes (1)
- Response Deadline: Apr 07, 2026 → Apr 13, 2026
Details
Award Information
Contacts
Contract Specialist